Suchergebnisse - "Qi, Yuekun"

PubPharm (12)

1

Clinical outcomes and microenvironment profiling of relapsed/refractory extramedullary disease of multiple myeloma patients with anti-BCMA CAR T cell-based therapy

enthalten in: ResearchSquare.com | 2024

von Qi, Y. | Li, H. | Qi, K. | +3

2

Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Ma, S. | Wang, Y. | Qi, K. | +12

3

Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia

enthalten in: Cancer immunology immunotherapy | 2024

von Ma, S. | Wang, Y. | Qi, K. | +12

4

Multi-centers experience using therapeutic plasma exchange for corticosteroid/tocilizumab-refractory cytokine release syndrome following CAR-T therapy

enthalten in: International immunopharmacology | 2024

von Pu, Y. | Zhao, Y. | Qi, Y. | +9

5

Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma

enthalten in: Cytotherapy | 2023

von Ma, S. | Li, H. | Zhou, D. | +18

6

Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma : A Single-Arm, Phase Ⅱ Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Xia, J. | Li, H. | Yan, Z. | +24

7

Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myeloma

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2023

von Zhou, D. | Wang, Y. | Cheng, H. | +16

8

Efficacy and safety of CD19-specific CAR T cell-based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

enthalten in: Blood | 2022

von Qi, Y. | Zhao, M. | Hu, Y. | +21

9

Impact of glucocorticoids on short-term and long-term outcomes in patients with relapsed/refractory multiple myeloma treated with CAR-T therapy

enthalten in: Frontiers in immunology | 2022

von Wang, X. | Qi, Y. | Li, H. | +10

10

Efficacy and safety of CD19-specific CAR-T cell-based therapy in secondary central nervous system lymphoma

enthalten in: Frontiers in immunology | 2022

von Zhang, H. | Yan, Z. | Wang, Y. | +24